What your CSV infrastructure would reveal today

Audit preparation has a timing problem. Most organizations start it in the weeks before an inspector arrives, which means what gets presented is not a picture of how the system runs day-to-day. It is a picture of how well the team could reconstruct the system's history under deadline pressure.

Those are not the same thing, and regulators increasingly know it. Between July and early December 2025, the FDA issued 327 warning letters, a 73 percent increase over the same period in 2024. The citations inside them cluster around a small set of familiar problems: data integrity gaps, weak CAPA systems, audit trails that were generated but never reviewed. None of this is new territory. What's changed is the frequency, and what that says about how many organizations are still managing validation as an event rather than a capability.

Five questions, one diagnostic

An audit does not test whether an organization can produce documentation. It tests whether the documentation was already true before anyone asked for it. Five areas tend to carry the weight of that test.

Validation documentation. Requirements, test scripts, and results should already be complete and current, not reconstructed retroactively. If assembling them requires tracking down five different people's memories of a decision made eighteen months ago, the documentation was never finished. A validation package that documents what happened without documenting why it happened is not evidence. It is paperwork wearing the costume of evidence, and auditors have gotten good at telling the difference.

Internal audits. Organizations that run these regularly, and treat the findings as credible evidence rather than a compliance formality, catch their own gaps before an external auditor does. Organizations that treat internal audits as a paperwork exercise find out the hard way that the gaps were there all along. The difference shows up in tone before it shows up in findings. A team that expects to find something during an internal audit behaves differently than a team that expects the audit to confirm what everyone already believes. One is diagnosing. The other is performing.

Traceability. Requirements should connect to test scripts, test scripts should connect to results, and results should connect back to the original intended use. When that chain breaks anywhere, every downstream conclusion built on it becomes questionable. A single broken link does not just weaken one requirement. It weakens the credibility of everything the auditor has already reviewed, because now there is reason to check the rest by hand instead of by trust.

Regulatory alignment. GxP and FDA expectations are not static, and the compliance model has to track the current standard, not the standard in place when the system was first validated. A validation strategy written for guidance that is three revisions old and never revisited looks compliant until someone checks the date on it.

Staff readiness. Documentation without a team that understands the procedures behind it is a liability during an actual audit, when someone has to explain the reasoning out loud, not just point to a binder. An auditor asking a validation lead to walk through a decision is not asking to see the document again. They are asking whether the organization made that decision with intention, or whether someone wrote it down because a template required a decision to exist somewhere on paper.

What validation debt costs

Every one of these five gaps has a name inside the DQI Framework: validation debt. It behaves the way financial debt behaves. Small unresolved gaps do not disappear because no one is looking at them. They sit on the books, drawing interest, until an inspector, a customer audit, or a product failure forces a reckoning at the worst possible moment.

Cost of poor quality rarely shows up on a line item labeled that way, which is exactly why so few executives track it as one number. It shows up as remediation projects that could have been prevented at a fraction of the cost. It shows up as CAPA timelines that stretch past their own committed dates because the root cause was never fully understood the first time. It shows up as engineering hours spent reconstructing a decision that should have taken five minutes to document when it was made. None of that is hypothetical. It is the ordinary, recurring cost of running validation as an event instead of a capability, paid in installments most organizations never add up until an inspector adds them up first.

The regulatory floor is moving, not the requirements.

The FDA's Computer Software Assurance guidance changes the evidence model toward risk-proportionate assurance. It doesn't remove the underlying controls: audit trails, e-signatures, and Part 11 requirements are all still mandatory. The EU is moving in a similar direction: draft revisions to GMP Annex 11 and a newly proposed Annex 22 covering AI in GMP-critical applications were published for consultation in July 2025, with a final version still pending as of this writing. Neither region is loosening what organizations have to demonstrate. Both are changing how much documentation is required to demonstrate it, in favor of evidence that's proportionate to actual risk.

That convergence rewards organizations that already treat validation as continuous. It penalizes organizations still assembling proof of compliance retrospectively, because a risk-based model has less patience for paper that exists only to be produced on demand. Organizations waiting for a final rule before adjusting their evidence model will spend the next review cycle catching up to a standard that took effect in practice well before it took effect on paper. Regulators have already signaled where the risk-based floor sits. A final text will formalize that floor. It will not invent it.

A diagnostic, not a sprint.

Audit preparation, done well, isn't a separate activity at all. It's the byproduct of a system lifecycle where every decision was made consciously, documented so it's defensible later, and maintained continuously rather than revisited only under pressure. That's the difference between an organization that responds to an audit and one that was already prepared for it, because readiness was engineered into the system from the first day it went live.

None of this requires more paperwork. It requires deciding, once, that every validation decision will be conscious, documented so it holds up later, and revisited on a fixed cadence instead of left to calcify. That decision costs almost nothing to make. Avoiding it costs a great deal more, and the bill always arrives at the worst possible time.

What would a look at your CSV infrastructure reveal about which of those two organizations you're running?